Nice photo & well done #ASH26 @ASH_hematology 😀!!!! @TapKadia @JenMarvinPeek @HannahGoulart

🧬 Session 8 at #iwAL26: Transplantation in AML, chaired by Charles Craddock (@charliecraddock) & Victoria Potter! Charles Craddock on reducing relapse risk post-transplant, Samer Srour on precision-engineered T-cell therapy for alloHSCT, then a debate on pre-transplant intervention in MRD+ AML CR1 🥊 @TapKadia (yes) vs. Victoria Potter (no) 🥊 #iwAL #AML #LeuSM

Ready for The Five Under 5 🕘? Here is your go-to roundup of the top 5 #OncLiveTV 📹 videos of last week. @JuliaRotow @TapKadia @drgandara @GabyHobbs @DanaFarber @UCD_Cancer @MassGeneralNews #hematology #oncology Watch the clips that made the list 🔗: onclive.com/view/five-under-…

🏆First #Leukemia fellowship #Alumni of @UTMDAnderson gathering after #SOHO26 🔥 Such a great time connecting with friends, colleagues, & former fellows ⏭️ Join us for future editions coming up at the upcoming meetings

Saturday, Sept 12 — Session XIV: Next Questions Join @TapKadia at #SOHO2026 for Next Questions: Acute Myeloid Leukemia, a forward‑looking discussion on the key challenges, opportunities, and unanswered questions shaping the future of #AML research and patient care. @UTMDAnderson

A second opinion at UT MD Anderson revealed Jessica Smither actually had two different types of leukemia, instead of only one. How our Dr. Tapan Kadia's expertise changed her treatment plan and put both cancers into remission. @TapKadia #EndCancer

Our most recent update of CLAD+LDAC+Ven now published - almost 200 pts with ~3yr f/u ; CR rate 84% and 92% in TP53 wildtype. @alexbataller onlinelibrary.wiley.com/doi/…

👏Important new paper from our group led by .@TapKadia & @AlexBataller 👉just out in @AjHematology | #Cladribine #leusm #endcancer | @sanamloghavi onlinelibrary.wiley.com/doi/…

Results from a Phase 2 trial showed that a lower-intensity treatment regimen may be highly effective in some subsets of patients with acute myeloid leukemia. Learn more: spr.ly/6014BBQgAk @tapkadia #EndCancer

Triple- nucleosides plus venetoclax result in outstanding outcomes in older #AML doi.org/10.1002/ajh.70328 @AjHematology @UTMDAnderson

Just wrapped up an incredible ASH convention! Grateful for the opportunity to be part of the leukemia fellowship @MDAndersonNews @garciamanero @TapKadia @r_sazevedo #leukemia #ASH25 @Apsingh_MD

Great presentation by @jenweiying summarizing the frontline data with Oral Dac Ven Revumenib in patients with newly diagnosed NPM1-m and KMT2a-r AML. #ASH2025 @MDAndersonNews

Big thanks to Drs. David A. Sallman, @Tapkadia and @dremmasearle for an outstanding #ASH25 #AML session—packed with practical insights for everyday clinical care. 📺 Catch the replay: bit.ly/2025-AML-T Grateful for grant support from @JNJInnovMed, @kuraoncology and @Syndax, and for our collaboration with @HealthTree! #CME #MedEd

#ASH25 | Wow!! Thanks 🙏 to @ASH_hematology for featuring our @MDAndersonNews Leukemia team in the #ASH25 Program Guide with the reminder save the date for #ASH26 !!!!! | @TapKadia @drsangeetmd @JenMarvinPeek @HannahGoulart @doctorpemm @CRausch_PharmD @FadiHaddad_MD @NitinJainMD

Our latest from @MDAndersonNews sharing the largest series of these cases to date. onlinelibrary.wiley.com/doi/… @jenweiying @TapKadia @BrJHaem

Read the cell, guess the genetics. #HemePath #Genetics #leusm #AMLsm 🔬🧬🩸

We report incidence of NPM1-wildtype relapses in pts treated with VEN-based frontline tx in AML.   🔴Overall, absolute # of relapses in NPM1 AML after VEN is ⬇️  🔴the fraction of NPM1-wildtype relapses ⬆️ with the⬆️ intensity of chemo backbone added to VEN.  🔴 NPM1 wildtype relapses occur later and often had MR mutations.  And ALL (8/8) had a different flow immunophenotype compared to original AML.  🔴We proposed that these were ‘new’ AMLs, that arose from common preleukemic (CH) precursor, but that the original NPM1-mutated AML was ‘cured’. onlinelibrary.wiley.com/acti… @AjHematology

Investigational CPX-531 plus venetoclax may be a salvage therapy option for relapsed or refractory #AML @TapKadia @AjHematology sohoinsider.com/leukemia/acu…

Triplet therapy maintains, improves quality of life in relapsed/refractory myeloma sohoinsider.com/news/belanta…